Cardiology (all articles) | Page 29 of 178 | Links Medicus Content Curation & Alerts in Medicine

Cohort Study | Survival of patients with congenital ventricular septal defect.

13 Dec, 2022 | 14:21h | UTC

Survival of patients with congenital ventricular septal defect – European Heart Journal

Commentary: Survival of Patients With Congenital Ventricular Septal Defect – American College of Cardiology

Commentary on Twitter

Survival of patients with congenital ventricular septal defect https://t.co/Qr8dLv4w2h @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/aWeFfbFP4V

— European Society of Cardiology Journals (@ESC_Journals) November 29, 2022

Cohort Study | Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction.

13 Dec, 2022 | 14:20h | UTC

Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study – European Heart Journal

Commentary on Twitter

Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study@escardio @ESC_Journals #CardioTwitter #EHJ #myocardialinfarction https://t.co/8QqhgkvZY4 pic.twitter.com/OBGMLH7Enl

— EHJ Editor-in-Chief (@ehj_ed) November 27, 2022

Under a https://creativecommons.org/licenses/by-nc/4.0/ license

AHA Scientific Statement | Complementary and alternative medicines in the management of heart failure.

9 Dec, 2022 | 13:40h | UTC

Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association – Circulation

News Release: Some benefits, potential risks with alternative medicines for heart failure – American Heart Association

RCT | Expectant management or early ibuprofen for patent ductus arteriosus.

9 Dec, 2022 | 13:38h | UTC

Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary on Twitter

In this trial involving preterm infants with patent ductus arteriosus, expectant management was noninferior to ibuprofen therapy for the primary outcome of necrotizing enterocolitis, bronchopulmonary dysplasia, or death at 36 weeks. https://t.co/vzrpruce9F pic.twitter.com/fW09Sz8O8o

— NEJM (@NEJM) December 6, 2022

The ‘10 commandments’ for the 2022 ESC Guidelines on ventricular arrhythmias and prevention of sudden cardiac death.

9 Dec, 2022 | 13:29h | UTC

The ‘10 commandments’ for the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The 2022 ESC Guidelines for the management of patients with ventricular arrhythmias (VAs) and the prevention of sudden cardiac death (SCD) present an update of the 2015 guidelines. – European Heart Journal

Original Guideline: #ESCCongress | 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.

Consensus Paper | Evaluation and management of cancer patients presenting with acute cardiovascular diseases.

9 Dec, 2022 | 13:28h | UTC

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology—part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias – European Heart Journal. Acute Cardiovascular Care

The ‘Ten Commandments’ for the 2022 European Society of Cardiology guidelines on cardio-oncology.

#ESCCongress | 2022 ESC Guidelines on cardio-oncology.

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations – Annals of Oncology

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement from the American Heart Association – Circulation

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations – Revista Espanola de Cardiologia

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology—Part 1: acute coronary syndromes and acute pericardial diseases – European Heart Journal. Acute Cardiovascular Care

Brazilian Cardio-oncology Guideline – 2020 – Arquivos Brasileiros de Cardiologia

AHA Statement: Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors

Consensus Statement | Radiation protection for healthcare professionals working in catheterization laboratories during pregnancy.

9 Dec, 2022 | 13:26h | UTC

Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Heart Rhythm Association (EHRA), the European Association of Cardiovascular Imaging (EACVI), the ESC Regulatory Affairs Committee and Women as One – EuroIntervention

Commentary: Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs – TCTMD

Commentary on Twitter

A joint statement on radiation risk and the existing data on the experience of radiation-exposed cardiologists who continue to work in cath labs throughout their pregnancies. @SilbermanManzo @alaide_chief #EAPCI #CARDIOTWITTER https://t.co/UvCNN16klW pic.twitter.com/2kKR0KXf1X

— EuroIntervention (@EuroInterventio) November 22, 2022

RCT | Utility of coronary CT angiography for patients with suspected acute coronary syndrome.

9 Dec, 2022 | 13:22h | UTC

Prospective RandOmised Trial of Emergency Cardiac Computerised Tomography (PROTECCT) – Heart

Commentary on Twitter

PROTECCT Trial @Heart_BMJ shows that immediate coronary CT in ED does not reduce length of stay in patients with suspected #AcuteCoronarySyndrome that cannot be ruled in/out on first #Troponin. @TheBHF @kingscardio @KingsImaging @GSTTresearch https://t.co/ud4rxEpmKl pic.twitter.com/YmKXFWIBZd

— Cardiac Research (@UKheartresearch) October 27, 2022

Under a http://creativecommons.org/licenses/by-nc/4.0/ License

M-A | Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

9 Dec, 2022 | 13:20h | UTC

Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis – Heart

Cohort Study | Lipoprotein(a) in youth and prediction of major cardiovascular outcomes in adulthood.

9 Dec, 2022 | 13:11h | UTC

Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood – Circulation

Commentary: Lp(a) in Youth and Risk of ASCVD Outcomes in Adulthood – American College of Cardiology

Commentary on Twitter

#OriginalResearch Childhood Lp(a) levels are associated with significantly increased risk of develping ASCVD as adults @UTUpophealth @olraita #AHAJournals https://t.co/oqHv19QU6l pic.twitter.com/ByZmtRrXqy

— Circulation (@CircAHA) November 30, 2022

Preliminary study suggests that Edoxaban is a safe alternative for preventing thromboembolism in pediatric patients with cardiac disease.

9 Dec, 2022 | 13:07h | UTC

Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Editorial: Advancing Anticoagulation for Children With Cardiac Disease – Journal of the American College of Cardiology

Commentary: Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease – ENNOBLE-ATE – American College of Cardiology

Cohort Study | Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with CAD.

8 Dec, 2022 | 12:58h | UTC

Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with coronary artery disease – Heart Rhythm

Commentary: Poor R-wave progression is linked to sudden cardiac death: Study – Medical Dialogues

Commentary on Twitter

Poor R-wave progression as a predictor of sudden cardiac death in the general population and subjects with coronary artery disease – OPEN ACCESS! https://t.co/ScaZVvsbCU

— HeartRhythm (@hrs_journal) June 7, 2022

Cluster RCT | Effect of a multicomponent intervention delivered on a web-based platform on hypertension control.

8 Dec, 2022 | 13:02h | UTC

Effect of a Multicomponent Intervention Delivered on a Web-Based Platform on Hypertension Control: A Cluster Randomized Clinical Trial – JAMA Network Open

Commentary on Twitter

Cluster RCT: A multicomponent intervention aided by web-based platform improved blood pressure control vs. usual care in China. https://t.co/bsfK5TF1hs

— JAMA Network Open (@JAMANetworkOpen) December 7, 2022

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison.

8 Dec, 2022 | 12:57h | UTC

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison – ESC Heart Failure

Original Guidelines:

#ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.

#ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.

Featured Infographic | Recognizing Mendelian (Monogenic) CVD.

8 Dec, 2022 | 12:40h | UTC

Featured Infographic | Recognizing Mendelian (Monogenic) CVD – American College of Cardiology

Global is Local | Rheumatic heart disease around the world (including your clinic).

8 Dec, 2022 | 12:39h | UTC

Cover Story | Global is Local: Rheumatic Heart Disease Around the World (Including Your Clinic) – American College of Cardiology

M-A | Micronutrient supplementation to reduce cardiovascular risk.

7 Dec, 2022 | 14:25h | UTC

Micronutrient Supplementation to Reduce Cardiovascular Risk – Journal of the American College of Cardiology (link to abstract – $ for full-text)

News Release: Not all micronutrients created equal: Study identifies some supplements that benefit cardiovascular health – American College of Cardiology

Commentaries:

Micronutrient Supplementation to Reduce Cardiovascular Risk – American College of Cardiology

Study Identifies Some Supplements That Benefit CV Health – American College of Cardiology

Consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices.

7 Dec, 2022 | 14:23h | UTC

Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices – Heart

Commentary on Twitter

In this issue, read the Joint British Society consensus recommendations for MRI for patients with cardiac implantable electronic deviceshttps://t.co/tI1WhOfmaw pic.twitter.com/ncn0cLM4oU

— Heart_BMJ (@Heart_BMJ) September 30, 2022